Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate
Open accessAbstract
Photodynamic therapy using topical methyl 5-aminolevulinate (MAL) is a new treatment modality for basal cell carcinoma (BCC) and actinic keratosis (AK). MAL induces endogenous porphyrins, which act as photosensitizers. Pharmacokinetic studies of the porphyrin-inducing effect of MAL creams (Metvix) applied in different concentrations (16-160 mg/g) and application times are presented. Surface fluorescence measurements were used to monitor porphyrin accumulation in 18 superficial BCCs and 32 AKs. For both lesion types, the fluorescence increased during the first 13 of 28 hours of continuous MAL application. A 20-fold site-to-site variation was observed, and there were no significant MAL concentration dependencies. The selectivity between lesions and normal skin was 10-fold during the first hours and decreased throughout the application time. Fluorescence microscopy images of tissue sections from 32 nodular BCCs were analyzed to calculate the porphyrin content in tumor tissue as a function of depth. Significant correlation to MAL concentration was seen within the tumors treated for 3 hours. Increase to 18-hour MAL application enhanced the fluorescence levels in superficial tumor layers, but not in deep layers. In conclusion, application of the 160 mg/g cream for 3 hours gave advantageous porphyrin distributions for all types of lesions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A 10-fold difference was observed between lesional skin and normal skin in the first hours after application of MAL.
“A 10-fold difference was observed between lesional skin and normal skin in the first hours after application of MAL.”
From Photodynamic Therapy for Non-Melanoma Skin Cancers (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., & Peng, Q. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.889 · Cited by 4,716 · see citing works
Gomer, C. J. (1988) · Cited by 4,169 · see citing works
Photodynamic therapy with endogenous protoporphyrin
Kennedy, J. C., Pottier, R. H., & Pross, D. C. (1990) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(90)85083-9 · Cited by 1,509 · see citing works
5-Aminolevulinic Acid-Based Photodynamic Therapy: Principles and Experimental Research
Peng, Q., Berg, K., Moan, J., Kongshaug, M., & Nesland, J. M. (1997) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1997.tb08549.x · Cited by 615 · see citing works
Self-citationMorton, C. A., Brown, S. B., Collins, S. M., Ibbotson, S. H., Jenkinson, H., Kurwa, H. A., Langmack, K. A., McKenna, K. E., Moseley, H., Pearse, A. D., et al. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04719.x · Cited by 446 · see citing works
Szeimies, R. (2002) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(02)00056-7 · Cited by 434 · see citing works
Photodynamic Therapy Using Topical Methyl Aminolevulinate vs Surgeryfor Nodular Basal Cell Carcinoma
Rhodes, L. E., de Rie, M. A., Enström, Y., Groves, R. W., Morken, T., Goulden, V., Wong, G. A. E., Grob, J., Varma, S., & Wolf, P. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.1.17 · Cited by 356 · see citing works
Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid
Wolf, P., Rieger, E., & Kerl, H. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70002-b · Cited by 338 · see citing works
Pariser, D. M., Lowe, N. J., Stewart, D. M., Jarratt, M. T., Lucky, A. W., Pariser, R. J., & Yamauchi, P. S. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.49 · Cited by 302 · see citing works
Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins
Malik, Z., & Lugaci, H. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.246 · Cited by 292 · see citing works
Freeman, M., Vinciullo, C., Francis, D., Spelman, L., Nguyen, R., Fergin, P., Thai, K., Murrell, D., Weightman, W., Anderson, C., et al. (2003) · Journal of Dermatological Treatment · doi:10.1080/09546630310012118 · Cited by 285 · see citing works
Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture.
Gaullier, J., Berg, K., Peng, Q., Anholt, H., Selbo, P. K., Ma, L. W., & Moan, J. E. (1997) · PubMed · Cited by 257 · see citing works
Lange, N., Jichlinski, P., Zellweger, M., Forrer, M., Martí, A., Guillou, L., Kučera, P., Wagnières, G., & van den Bergh, H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690338 · Cited by 229 · see citing works
Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters
Lopez, R. F. V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.09.002 · Cited by 225 · see citing works
Soler, A., Warloe, T., Berner, A., & Giercksky, K. E. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04407.x · Cited by 224 · see citing works
Peng, Q., Soler, A. M., Warloe, T., Nesland, J. M., & Giercksky, K.-E. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00173-7 · Cited by 218 · see citing works
Peng, Q., Moan, J. E., & Nesland, J. M. (1996) · Ultrastructural Pathology · doi:10.3109/01913129609016306 · Cited by 213 · see citing works
Horn, M., Wolf, P., Wulf, H. C., Warloe, T., Fritsch, C., Rhodes, L. E., Kaufmann, R., de Rie, M. A., Legat, F. J., Stender, I., et al. (2003) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2003.05600.x · Cited by 202 · see citing works
Fritsch, C., Homey, B., Stahl, W., Lehmann, P., Ruzicka, T., & Sies, H. (1998) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1998.tb02492.x · Cited by 192 · see citing works
Prodrugs of 5‐Aminolevullinic Acid for Photodynamic Therapy
Kloek, J., & van Henegouwen, G. M. J. B. (1996) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1996.tb01868.x · Cited by 182 · see citing works
DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA
Peng, Q., Warloe, T., Moan, J., Heyerdahl, H., Steen, H. B., Nesland, J. M., & Giercksky, K. (1995) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1995.tb09154.x · Cited by 178 · see citing works
NON‐INVASIVE TECHNIQUE FOR OBTAINING FLUORESCENCE EXCITATION AND EMISSION SPECTRA IN VIVO
Pottier, R., Chow, Y. F. A., Laplante, J. P., Truscott, T. G., Kennedy, J. C., & Beiner, L. A. (1986) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1986.tb04726.x · Cited by 176 · see citing works
Rud, E., Gederaas, O. A., Høgset, A., & Berg, K. (2000) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2000)0710640aabnaa2.0.co2 · Cited by 170 · see citing works
Tope, W. D., Martín, A., Grevelink, J. M., STARR, J. C., Fewkes, J. L., Flotte, T. J., Deutsch, T. F., & Anderson, R. R. (1995) · Archives of Dermatological Research · doi:10.1007/bf00371740 · Cited by 145 · see citing works
Wiegell, S. R. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.9.1173 · Cited by 142 · see citing works
Peng, Q., Evensen, J. F., Rimington, C., & Moan, J. E. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90096-6 · Cited by 106 · see citing works
Rosa, F. S. D., Tedesco, A. C., Lopez, R. F. V., Pierre, M. B. R., Lange, N., Marchetti, J. M., Rotta, J. C. G., & Bentley, M. V. L. B. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00125-1 · Cited by 104 · see citing works
Soler, A. (1999) · Acta Dermato Venereologica · doi:10.1080/000155599750010977 · Cited by 86 · see citing works
Dosimetry model for photodynamic therapy with topically administered photosensitizers
Svaasand, L. O., Wyss, P., Wyss-Desserich, M.-T., Tadir, Y., Tromberg, B. J., & Berns, M. W. (1996) · Lasers in Surgery and Medicine · doi:10.1002/(sici)1096-9101(1996)18:2 · Cited by 81 · see citing works
af Klinteberg, C., Enejder, A. M. K., Wang, I., Andersson‐Engels, S., Svanberg, S. R., & Svanberg, K. (1999) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(99)00045-7 · Cited by 76 · see citing works
Sinaasappel, M., & Sterenborg, H. J. C. M. (1993) · Applied Optics · doi:10.1364/ao.32.000541 · Cited by 73 · see citing works
Meng, J.-Y., Kataoka, H., Itoh, H., & Koono, M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200102)9999:9999 · Cited by 64 · see citing works
Casas, A. G., Perotti, C., Fukuda, H., Rogers, L. M.-A., BUTLER, A. R., & Batlle, A. M. D. C. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2156 · Cited by 46 · see citing works
Perotti, C., Casas, A. G., Fukuda, H., SACCA, P. A., & Batlle, A. M. D. C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600559 · Cited by 44 · see citing works
van den Akker, J. T. H. M., Holroyd, J. A., Vernon, D. I., Sterenborg, H. J. C. M., & Brown, S. B. (2003) · Lasers in Surgery and Medicine · doi:10.1002/lsm.10212 · Cited by 44 · see citing works
Golub, A. L., Dickson, E. F. G., Kennedy, J. C., Marcus, S. L., Park, Y., & Pottier, R. (1999) · Lasers in Medical Science · doi:10.1007/s101030050032 · Cited by 43 · see citing works
Bigelow, C. E., Mitra, S., Knuechel, R., & Foster, T. H. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1977 · Cited by 41 · see citing works
Tunstall, R. G., Barnett, A. A., Schofield, J., Griffiths, J., Vernon, D. I., Brown, S. B., & Roberts, D. J. H. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600460 · Cited by 37 · see citing works
Newell, B. A., Bedlow, A. J., Cliff, S. H., Drysdale, S. B., Stanton, A. W. B., & Mortimer, P. S. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05325.x · Cited by 36 · see citing works
Thompson, M. S., Gustafsson, L., Pålsson, S., Bendsøe, N., Stenberg, M., af Klinteberg, C., Andersson‐Engels, S., & Svanberg, K. (2001) · Journal of Porphyrins and Phthalocyanines · doi:10.1002/jpp.325 · Cited by 15 · see citing works
Berner, A. (1999) · Acta Dermato Venereologica · doi:10.1080/000155599750011408 · Cited by 11 · see citing works
Moan, J. E., Hoydalsvik, E., Peng, Q., Ma, L. W., Warloe, T., & Heyerdahl, H. (1994) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.203404 · Cited by 4 · see citing works
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Rhodes LE, de Rie M, Enstrom Y, Groves R, Morken T, Goulden V et al. (2004) Photodynamic therapy using topical methyl aminolevulinate vs surgery 270 Journal of Investigative Dermatology (2006), Volume 126
Cited by
Sorted by citations
Braathen, L. R., Szeimies, R., Basset‐Séguin, N., Bissonnette, R., Foley, P. A., Pariser, D. M., Roelandts, R., Wennberg, A., & Morton, C. A. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.06.006 · Cited by 658 · see citing works
Beyond the margins: real-time detection of cancer using targeted fluorophores
Zhang, R. R., Schroeder, A. B., Grudzinski, J. J., Rosenthal, E. L., Warram, J. M., Pinchuk, A. N., Eliceiri, K. W., Kuo, J. S., & Weichert, J. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.212 · Cited by 485 · see citing works
Guidelines for topical photodynamic therapy: update
Morton, C. A., McKenna, K. E., & Rhodes, L. E. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08882.x · Cited by 469 · see citing works
Wiegell, S. R., Hædersdal, M., Philipsen, P. A., Eriksen, P., Enk, C. D., & Wulf, H. C. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08450.x · Cited by 344 · see citing works
Rhodes, L. E., de Rie, M. A., Leifsdottir, R., Yu, R. C., Bachmann, I., Goulden, V., Wong, G. A. E., Richard, M.-A., Anstey, A., & Wolf, P. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.9.1131 · Cited by 275 · see citing works
“of lesions 0 0 1 2 2 Proportion (95% CI) of lesions, % 0 (0-100) 0 (0-100) 2 (0-10) 4 (1-13) 4 (1-13)c Lesion size, mmd 10 0 0 0 0 0 10 and 20 0 0 1 2 2”
Influential5‐Aminolevulinic Acid Derivatives in Photomedicine: Characteristics, Application and Perspectives
Fotinos, N., Campo, M. A., Popowycz, F., Gurny, R., & Lange, N. (2006) · Photochemistry and Photobiology · doi:10.1562/2006-02-03-ir-794 · Cited by 238 · see citing works
“eficial with respect to selectivity (144).”
Rubel, D. M., Spelman, L. J., Murrell, D. F., See, J., Hewitt, D., Foley, P. A., Bosc, C., Kérob, D., Kerrouche, N., Wulf, H. C., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13138 · Cited by 223 · see citing works
Daylight photodynamic therapy for actinic keratosis: an international consensus
Wiegell, S. R., Wulf, H. C., Szeimies, R., Basset‐Séguin, N., Bissonnette, R., Gerritsen, M., Gilaberte, Y., Calzavara‐Pinton, P., Morton, C. A., Sidoroff, A., et al. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04386.x · Cited by 221 · see citing works
Current evidence and applications of photodynamic therapy in dermatology
Lin, J., & Wan, M. T. (2014) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s35334 · Cited by 248 · see citing works
Morton, C. A., Campbell, S. M., Gupta, G., Keohane, S. G., Lear, J. T., Zaki, I., Walton, S., Kerrouche, N., Thomas, G., Soto, P., et al. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07470.x · Cited by 211 · see citing works
Review of photodynamic therapy in actinic keratosis and basal cell carcinoma
Larkö, O. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1769 · Cited by 185 · see citing works
“There are indications that MAL is more selective towards neoplastic tissue compared to ALA (Angell-Petersen et al 2006), although there is a lack of comparing studies verifying this relationship.”
Wiegell, S. R., Fabricius, S., Stender, I., Berne, B., Kroon, S., Andersen, B. L., Mørk, C., Sandberg, C., Jemec, G. B. E., Mogensen, M., et al. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10209.x · Cited by 175 · see citing works
Wiegell, S. R., Hædersdal, M., Eriksen, P., & Wulf, H. C. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09119.x · Cited by 173 · see citing works
Lehmann, P. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07833.x · Cited by 156 · see citing works
Kaufmann, R., Spelman, L. J., Weightman, W., REIFENBERGER, J., Szeimies, R., Verhaeghe, E., Kerrouche, N., Sorba, V., Villemagne, H., & Rhodes, L. E. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08488.x · Cited by 145 · see citing works
Sorbellini, E., Rucco, M., & Rinaldi, F. (2018) · Lasers in Medical Science · doi:10.1007/s10103-018-2584-8 · Cited by 135 · see citing works
Photodynamic Therapy for Non-Melanoma Skin Cancers
Cohen, D., & Lee, P. (2016) · Cancers · doi:10.3390/cancers8100090 · Cited by 128 · see citing works
“Although there are no selectivity studies comparing MAL and ALA directly, it is presumed that MAL shows a greater selectivity than ALA, likely attributed to the differing uptake mechanisms [18].”
BackgroundFang, Y., Huang, Y., Wu, P., & Tsai, Y. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.07.011 · Cited by 122 · see citing works
“Most clinical investigators employed a keratolytic agent as a pretreatment or surgery to remove the scaling on the skin surface [18,19].”
BackgroundMosterd, K., Thissen, M. R. T. M., Nelemans, P. J., Kelleners-Smeets, N. W. J., Janssen, R. L. L. T., Broekhof, K. G. M. E., Neumann, H. A. M., Steijlen, P. M., & Kuijpers, D. I. M. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08787.x · Cited by 123 · see citing works
Hædersdal, M., Katsnelson, J., Sakamoto, F. H., Farinelli, W. A., Doukas, A. G., Tam, J., & Anderson, R. R. (2011) · Lasers in Surgery and Medicine · doi:10.1002/lsm.21096 · Cited by 110 · see citing works
“shown that there is a lack of PpIX fluorescence in deep tumor areas following ALA and MAL incubation [16,18,19].”
BackgroundCurrent Evidence and Applications of Photodynamic Therapy in Dermatology
(2015) · Journal of the Dermatology Nurses’ Association · doi:10.1097/jdn.0000000000000135 · Cited by 109 · see citing works
Pariser, D. M., Loss, R. W., Jarratt, M., Abramovits, W., SPENCER, J. M., Geronemus, R. G., Bailin, P., & Bruce, S. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.05.031 · Cited by 106 · see citing works
Zane, C., Capezzera, R., Sala, R., Venturini, M., & Calzavara‐Pinton, P. (2007) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20470 · Cited by 96 · see citing works
“Protoporphyrin IX (PpIX) can accumulate, although at a lower extent, also in the keratinocytes of the surrounding skin [23] and their sublethal photodynamic damage could increase the epidermal turnover and reduce the increased thickness of stratum corneum and granular cell layer that provokes the tactile dryness and r…”
BackgroundA review of photodynamic therapy in cutaneous leishmaniasis
van der Snoek, E. M., Robinson, D., van Hellemond, J. J., & Neumann, H. A. M. (2008) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2008.02805.x · Cited by 85 · see citing works
Choi, S.-H., Kim, K. H., & Song, K. H. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13542 · Cited by 81 · see citing works
Daylight‐mediated photodynamic therapy of basal cell carcinomas – an explorative study
Wiegell, S. R., Skødt, V., & Wulf, H. C. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12076 · Cited by 79 · see citing works
Ko, D.-Y., Jeon, S. ‐., Kim, K., & Song, K. H. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12334 · Cited by 75 · see citing works
Foley, P., Freeman, M., Menter, A., Siller, G., El‐Azhary, R. A., Gebauer, K., Lowe, N. J., Jarratt, M. T., Murrell, D. F., Rich, P., et al. (2009) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2008.04022.x · Cited by 92 · see citing works
Ablative Fractional Resurfacing in Topical Drug Delivery: An Update and Outlook
Bloom, B. S., Brauer, J. A., & Geronemus, R. G. (2013) · Dermatologic Surgery · doi:10.1111/dsu.12111 · Cited by 71 · see citing works
Endogenous and Exogenous Fluorescence Skin Cancer Diagnostics for Clinical Applications
Borisova, E. G., Angelova, L., & Pavlova, E. P. (2013) · IEEE Journal of Selected Topics in Quantum Electronics · doi:10.1109/jstqe.2013.2280503 · Cited by 69 · see citing works
Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses
Braathen, L. R., Paredes, B., Saksela, O., Fritsch, C., Gardlo, K., Morken, T., Frölich, K., Warloe, T., Soler, A., & Ros, A. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2008.03029.x · Cited by 69 · see citing works
Ko, D. Y., Kim, K. H., & Song, K. H. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12627 · Cited by 67 · see citing works
Photodynamic therapy in urology: What can we do now and where are we heading?
Bozzini, G., Colin, P., Betrouni, N., Nevoux, P., Ouzzane, A., Puech, P., Villers, A. A., & Mordon, S. R. (2012) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2012.01.005 · Cited by 61 · see citing works
Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses
O’Gorman, S. M., Clowry, J., Manley, M., McCavana, J., Gray, L., Kavanagh, A., Lally, A., & Collins, P. M. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.5436 · Cited by 58 · see citing works
Choi, S.-H., Kim, K. H., & Song, K. H. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13453 · Cited by 57 · see citing works
Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas
Christensen, S. R. (2018) · F1000Research · doi:10.12688/f1000research.12837.1 · Cited by 73 · see citing works
Choi, S.-H., Kim, K. H., & Song, K. H. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12953 · Cited by 54 · see citing works
Basset‐Séguin, N., Bissonnette, R., Girard, C., Hædersdal, M., Lear, J. T., Paul, C. F., & Piaserico, S. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12150 · Cited by 48 · see citing works
Valentine, R. M., Ibbotson, S. H., Brown, C. T. A., Wood, K., & Moseley, H. (2011) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2010.00829.x · Cited by 47 · see citing works
Fluorescence diagnosis in keratinocytic intraepidermal neoplasias
Smits, T., Kleinpenning, M. M., Blokx, W. A. M., van de Kerkhof, P. C. M., van Erp, P. E. J., & Gerritsen, M. P. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.06.031 · Cited by 43 · see citing works
Terapia fotodinâmica em dermatologia: princípios básicos e aplicações
Torezan, L. A. R., Niwa, A. B. M., & Neto, C. F. (2009) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962009000500002 · Cited by 40 · see citing works
Zhou, X., SHUXIAN, Y., Zhong, L., HUI, Q., YAN, W., HUILIN, D., Xiang, L. F., & Gold, M. H. (2010) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2010.01726.x · Cited by 41 · see citing works
“It is clinically well recognized that PDT can improve the appearance of tactile skin roughness, which is associated with the accumulation of PpIX, although to a lower extent, in the abnormally proliferated KCs.(15) Excessive reactive oxygen species (ROS) produced by IPL irradiation helps to destroy those old, poorly f…”
BackgroundActinic keratosis: update on field therapy.
Goldenberg, G., & Perl, M. (2014) · PubMed Central · Cited by 40 · see citing works
Savoia, P., Deboli, T., Previgliano, A., & Broganelli, P. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023300 · Cited by 39 · see citing works
“Currently, the only photosensitizers approved for dermatologic indications are aminolevulinic acid (ALA) and methyl aminolevulinate (MAL); both are prodrugs that require conversion to photo-activable porphyrin [55].”
BackgroundTierney, E. P., Petersen, J., & Hanke, C. W. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.03.045 · Cited by 36 · see citing works
Piffaretti, F. M., Zellweger, M., Kasraee, B., Barge, J., Salomon, D., van den Bergh, H., & Wagnières, G. (2013) · Dermatology · doi:10.1159/000353775 · Cited by 35 · see citing works
Mikolajewska, P., Iani, V., Juzeniene, A., & Moan, J. E. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09437.x · Cited by 35 · see citing works
Valentine, R. M., Wood, K., Brown, C. T. A., Ibbotson, S. H., & Moseley, H. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/20/6327 · Cited by 34 · see citing works
“While published data on photosensitizer distributions in skin tumours is relatively limited, Angell-Petersen et al (2006) and Kruijt et al (2008) have reported on experimental heterogeneous photosensitizer distributions, which could possibly influence photosensitizer photobleaching and in turn…”
BackgroundKessels, J. P. H. M., Kreukels, H., Nelemans, P. J., Roozeboom, M. H., van Pelt, H., Mosterd, K., de Haas, E. R. M., & Kelleners-Smeets, N. W. J. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15967 · Cited by 31 · see citing works
Daylight-PDT: Everything under the Sun
Beiki, D., Eggleston, I. M., & Pourzand, C. (2022) · Biochemical Society Transactions · doi:10.1042/bst20200822 · Cited by 31 · see citing works
MAL-PDT for difficult to treat nonmelanoma skin cancer
Stebbins, W. G., & Hanke, C. W. (2011) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01381.x · Cited by 30 · see citing works
“MAL is also more selectively absorbed by neoplastic cells by a factor of 10 : 1 compared with surrounding normal tissue (21).”
BackgroundJuzeniene, A., & Moan, J. E. (2006) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2006.11.001 · Cited by 30 · see citing works
Togsverd‐Bo, K., Lerche, C. M., Poulsen, T., Wulf, H. C., & Hædersdal, M. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.01035.x · Cited by 28 · see citing works
Zhang, Y., Liu, W., & Wang, Q. (2023) · Journal of Biophotonics · doi:10.1002/jbio.202200293 · Cited by 27 · see citing works
Nonsurgical Treatment of Nonmelanoma Skin Cancer
Galiczynski, E. M., & Vidimos, A. T. (2011) · Dermatologic Clinics · doi:10.1016/j.det.2011.01.011 · Cited by 26 · see citing works
Won, Y., Hong, S. H., Yu, H., Kwon, Y. H., Yun, S. J., Lee, S. C., & Lee, J. B. (2007) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2007.02435.x · Cited by 25 · see citing works
Boiy, A., Roelandts, R., & de Witte, P. A. M. (2010) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2010.09.012 · Cited by 26 · see citing works
Lacava, Z. G. M., Passos, de Souza, Soares, Eĭd, Primo, F. L., Tedesco, A. C., & Morais (2013) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s36758 · Cited by 25 · see citing works
Angell‐Petersen, E., Christensen, C., Müller, C., & Warloe, T. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07638.x · Cited by 25 · see citing works
Mendoza‐Garcia, J., Sebastian, A., Allan, E., Allan, D., Mandal, P., Alonso-Rasgado, T. A., & Bayat, A. (2012) · Archives of Dermatological Research · doi:10.1007/s00403-012-1264-y · Cited by 25 · see citing works
“Aminolevulinic acid is an endogenous amino acid and has been promoted as a precursor for the photosensitising agent (PpIX) in PDT [4, 29, 32, 36].”
BackgroundPhotodynamic Therapy for Actinic Keratoses
Kalisiak, M. S., & Rao, J. (2007) · Dermatologic Clinics · doi:10.1016/j.det.2006.09.006 · Cited by 24 · see citing works
Photodynamic therapy with methyl aminolevulinate for atypia/carcinoma in situ of the penis
Axcrona, K., Brennhovd, B., Alfsen, G. C., Giercksky, K.-E., & Warloe, T. (2007) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590701428590 · Cited by 23 · see citing works
“PDT with Metvix has been shown to penetrate the skin to a depth of 2 3 mm [13].”
BackgroundMethodLerche, C. M., Fabricius, S., Philipsen, P. A., & Wulf, H. C. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c5pp00069f · Cited by 22 · see citing works
Fluorescence diagnosis in actinic keratosis and squamous cell carcinoma
Kleinpenning, M. M., Wolberink, E. A. W., Smits, T., Blokx, W. A. M., van de Kerkhof, P. C. M., van Erp, P. E. J., & Gerritsen, R. M. J. P. (2010) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2010.00546.x · Cited by 21 · see citing works
“After 3 h of incubation (11), the ointment and foils were removed and the skin surface was cleaned using 80% denaturated alcohol v/v.”
MethodKulyk, O., Ibbotson, S. H., Moseley, H., Valentine, R. M., & Samuel, I. D. W. (2015) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2015.10.002 · Cited by 18 · see citing works
Dewalle, A. S., Betrouni, N., Tylcz, J., Vermandel, M., Mortier, L., & Mordon, S. R. (2015) · Journal of Biomedical Optics · doi:10.1117/1.jbo.20.5.058001 · Cited by 18 · see citing works
“From the actinic keratosis data reported in Wiegell et al. [22], the time constant for the conversion of 5-ALA into PpIX, c (equation 7), is deduced to be 1.1575h,which is consistent with previously published values [39,40].”
van der Snoek, E. M., Amelink, A., van der Ende, M. E., den Hollander, J. C., den Hollander, J. G., Kroon, F. P., Vriesendorp, R., Neumann, H. A. M., & Robinson, D. J. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b05f93 · Cited by 18 · see citing works
Combination curettage and modified ALA-PDT for multiple basal cell carcinomas of the face and head
Liao, C., Zhang, G., Wang, P., Sun, X., & Wang, X. (2021) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2021.102393 · Cited by 18 · see citing works
Jeon, S.-Y., Kim, K., & Song, K. (2013) · Dermatologic Surgery · doi:10.1111/dsu.12359 · Cited by 18 · see citing works
Kamrava, S. K., Behtaj, M., Ghavami, Y., Shahmiri, S. S., Jalessi, M., Afshar, E. E., & Maleki, S. (2012) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2012.03.004 · Cited by 18 · see citing works
Nonsurgical Treatment Modalities for Primary Cutaneous Malignancies
Tull, S., Nunley, K. S., & Sengelmann, R. D. (2008) · Dermatologic Surgery · doi:10.1097/00042728-200807000-00001 · Cited by 16 · see citing works
Photodynamic Therapy for Patients with Basal Cell Nevus Syndrome
Gilchrest, B. A., Brightman, L. A., Thiele, J. J., & Wasserman, D. I. (2009) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2009.01279.x · Cited by 16 · see citing works
“PDT is use of a photosensitizing agent and activating wavelengths of light in the presence of oxygen to generate reactive oxygen species that destroy diseased tissue.2 Aminolevulinic acid (ALA), technically a prodrug, is metabolized in many tissues, including the epidermis, through the heme biosynthesis pathway primar…”
BackgroundFabricius, S., Lerche, C. M., Philipsen, P. A., & Wulf, H. C. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c2pp25128k · Cited by 14 · see citing works
Lee, S. J., Hwang, H., Shin, J., & Ahn, J. (2015) · General Physiology and Biophysics · doi:10.4149/gpb_2014025 · Cited by 13 · see citing works
“PDT using ALA as a photosensitizer is applied for the treatment of skin cancer, actinic keratosis, and other skin lesions (Cairnduff et al. 1994; Angell-Petersen et al. 2006).”
BackgroundVereecken, P. M., Costa, C. M. D., Steels, E., Lathouwer, O. D., Heenen, M., & Mey, A. D. (2007) · Acta chirurgica Belgica · doi:10.1080/00015458.2007.11680041 · Cited by 12 · see citing works
“Several reports however have demonstrated for basal cell carcinoma, actinic keratosis and Bowen’s disease an excellent correlation between fluorescence pattern and histopathology, and confirmed the specific accumulation of fluorescing molecules in these skin lesions (5, 6).”
BackgroundPhotodynamic therapy with aminolevulinic acid or its methyl ester: Which one is superior?
Krammer, B. E., & Verwanger, T. (2009) · Medical Laser Application · doi:10.1016/j.mla.2009.07.002 · Cited by 10 · see citing works
Dewalle, A. S., Baert, G., Devos, L., Thécua, E., Vicentini, C., Mortier, L., & Mordon, S. R. (2017) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22665 · Cited by 10 · see citing works
“biological clearance of PpIX and the conversion of MAL into PpIX were described using a single logistic growth model (equations 2 and 3), that is, according to [24,29,30], a more realistic model compared to the two exponential models used in our previous work [21].”
MethodAbrouk, M. E., Dong, J., & Waibel, J. S. (2021) · Lasers in Surgery and Medicine · doi:10.1002/lsm.23460 · Cited by 10 · see citing works
“PDT specifically targets the photo‐aged abnormally proliferating keratinocytes, in which PpIX accumulates, followed by activation of light with a suitable wavelength leading to the formation of ROS to destroy the target cells.(6,11) Both, the red light lamp as well as the IPL used in this study have the suitable wavel…”
BackgroundWan, M., Ma, H., Zhao, Y., Xie, L., & Chen, Z. (2017) · Dermatologic Surgery · doi:10.1097/dss.0000000000001329 · Cited by 10 · see citing works
Nguyen, K. P., Knuiman, G. J., Blokx, W. A. M., Hoogedoorn, L., Smits, T., & Gerritsen, M. (2018) · Journal of Dermatological Treatment · doi:10.1080/09546634.2018.1484558 · Cited by 9 · see citing works
“Further studies have tried to optimise fractionated ALA-PDT (18,19).”
BackgroundInfluentialDepth Profile of Protoporphyrin IX Fluorescence in an Amelanotic Mouse Melanoma Model
Juzenas, P., Juzeniene, A., Iani, V., & Moan, J. E. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00496.x · Cited by 9 · see citing works
Chemopreventative Thoughts for Photodynamic Therapy
Bissonnette, R. (2007) · Dermatologic Clinics · doi:10.1016/j.det.2006.09.011 · Cited by 9 · see citing works
Meng, Y., Chen, S., Li, P., Wang, C., & Ni, X. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01247 · Cited by 8 · see citing works
Kim, B., Lee, N. R., Park, S., Eom, M., & Choi, E. H. (2014) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12140 · Cited by 7 · see citing works
“Photodynamic therapy (PDT) has been widely used in treatment of various dermatologic diseases such as skin cancer and premalignant conditions (3, 4).”
BackgroundMiola, A. C., Ferreira, E. R., Abbade, L. P. F., Schmitt, J. V., & Miot, H. A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4288-7 · Cited by 7 · see citing works
“MAL is a precursor of protoporphyrin IX, which generates reactive oxygen in dysplastic keratinocytes when exposed to a light source with the appropriate wavelength [30].”
Leufflen, L., François, A., Salleron, J., Barlier, C., Dolivet, G., Marchal, F., & Bezdetnaya, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196753 · Cited by 7 · see citing works
5-aminolaevulinic acid-based photodynamic therapy inhibits ultraviolet B-induced skin photodamage
Hua, H., Cheng, J., Bu, W., Liu, J., Ma, W., Ni, N., Shi, J., Zhou, B., & Luo, D. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.31583 · Cited by 7 · see citing works
“ALA esters can notably improve skin uptake[17, 33, 34], but the porphyrin fluorescence of ALA and ALA methyl esters showed the same microscopical spatial distribution[35].”
BackgroundIs the thin layer of methyl aminolevulinate used during photodynamic therapy sufficient?
Wiegell, S. R., Lerche, C. M., & Wulf, H. C. (2015) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12227 · Cited by 6 · see citing works
“The PDT procedure includes occlusive treatment with methyl aminolevulinate (MAL) for 3 h, which results in a high and relatively selective accumulation of protoporphyrin IX (PpIX) in the lesions (1).”
MethodLima, C. A., Goulart, V. P., Bechara, E. J. H., Côrrea, L., & Zezéll, D. M. (2016) · Journal of Biophotonics · doi:10.1002/jbio.201600164 · Cited by 6 · see citing works
Effect of (R)L-sulforaphane on 5-aminolevulinic acid-mediated photodynamic therapy
Mikolajewska, P., Juzeniene, A., & Moan, J. E. (2008) · Translational research · doi:10.1016/j.trsl.2008.07.004 · Cited by 6 · see citing works
Trave, I., Salvi, I., Serazzi, F. A., Schiavetti, I., Luca, L., Parodi, A., & Cozzani, E. (2024) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2024.104049 · Cited by 5 · see citing works
Helgesen, A. L. O., Gjersvik, P. J., Peng, Q., Vasovič, V., Pripp, A. H., Jebsen, P., Tanbo, T. G., & Warloe, T. (2014) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2014.01.005 · Cited by 5 · see citing works
Campbell, C. L., Brown, C. T. A., Wood, K., Sálvio, A. G., Inada, N. M., Bagnato, V. S., & Moseley, H. (2017) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2017.02.004 · Cited by 5 · see citing works
Photodynamic Therapy For Non-Melanoma Skin Cancers
Monfrecola, G., Fabbrocini, G., & Calzavara‐Pinton, P. (2009) · Current Cancer Therapy Reviews · doi:10.2174/157339409789712663 · Cited by 4 · see citing works
“Although there are some doubts about the duration of ALA incubation, a 2-3 hours application was confirmed in a recent study [49].”
BackgroundRomero, M. P., Posso, V., Ureña, V., Inada, N. M., Bagnato, V. S., & Cabrera, F. (2022) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2022.102967 · Cited by 4 · see citing works
Fluorescence diagnosis of non-melanoma skin cancer
Gaál, M., Kui, R. K., Hunyadi, Z., Kemény, L. V., & Gyulai, R. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29424 · Cited by 3 · see citing works
Casey, S., Best, L., Vujovic, O., Jordan, K. J., Fisher, B., Carey, D., Bourdeau, D., & Yu, E. (2016) · Cureus · doi:10.7759/cureus.767 · Cited by 3 · see citing works
BSc, M. N. H. C., & John S. C. English MBBS, F. (2011) · Wiley eBooks · doi:10.1002/9781444329865.ch4 · Cited by 2 · see citing works
- Authors
- Angell-Petersen, E., Sørensen, R., Warloe, T., Soler, A. M., Moan, J., Peng, Q., & Giercksky, K.-E.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 126
- Issue
- 2
- Pages
- 265-271
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2135267652
- Cited by
- 123
- References
- 43
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 7 · 2013: 11 · 2012: 9
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Smith and Nephew
- Topics
- Health Sciences › Medicine › Epidemiology › Nonmelanoma Skin Cancer Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
- Keywords
- porphyrin accumulation, actinic keratosis, basal cell carcinoma, photodynamic therapy, topical photosensitizer, skin fluorescence, nodular basal cell carcinoma, superficial basal cell carcinoma
- MeSH terms
- Administration, Topical, Aged, Aminolevulinic Acid, Basal Cell Carcinoma, Double-Blind Method, Female, Humans, Keratosis, Male, Microscopy, Fluorescence, Monitoring, Physiologic, Ointments, Photochemotherapy, Porphyrins, Prospective Studies, Skin Neoplasms, Photosensitizing Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review